Rating History for Onyx Pharmaceuticals (ONXX) by Goldman Sachs
| Date | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/21/2012 | Maintain | Buy (N/A) |
63.00 (52.00) |
Details | |||
| 5/3/2012 | Downgrade | Buy (N/A) |
52.00 (N/A) |
45.00 | 93.59 | 107.98% | Details |
| 12/15/2011 | Upgrade | Conviction Buy (N/A) |
47.00 (N/A) |
38.15 | 45.00 | 17.96% | Details |
| 12/12/2011 | Maintain | Buy (N/A) |
45.00 (N/A) |
Details | |||
| 10/13/2011 | Maintain | Buy (N/A) |
44.00 (N/A) |
Details | |||
| 9/15/2011 | Upgrade | Buy (N/A) |
40.00 (N/A) |
31.05 | 38.15 | 22.87% | Details |
| 7/11/2011 | New Coverage | Neutral (N/A) |
N/A (N/A) |
36.58 | 31.05 | -15.12% | Details |
